No Data
No Data
Dow's Decline: Biggest Losers and Winners as Blue-chips Index Faces Q1 Loss
Express News | "Judge Tosses Amgen's Challenge To Colorado Drug Review Board, Says Suit Is 'Too Speculative'" - Endpoints News
Pfizer Ran What Could Be the Largest Tax Dodging Scheme Among Big Pharma: Senator
Express News | Fresenius Kabi: Launch of Conexxence & Bomyntra in the U.S. in Mid-2025 and in Europe Later in H2 of 2025
Express News | Fresenius Kabi: Reached a Global Settlement With Amgen Concerning Their Denosumab Biosimilars
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
sGpcGhost : y